DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Long GV, Tykodi SS, Schneider JG, Garbe C, Gravis G, Rashford M. et al.
Assessment of nivolumab exposure and clinical safety of 480 mg every 4 weeks flat-dosing schedule in patients with cancer.
Ann Oncol 2018;
29: 2208-13
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.